Printer Friendly

Public advocacy group asks federal court to force FDA to release records on xenotransplantation risks.

The Campaign for Responsible Transplantation (CRT), a New York-based "advocacy group" has asked the Federal District Court for the District of Columbia to compel the US Food and Drug Administration (FDA) to release records that they allege contain information on the potential risks of xenotransplantation.

The CRT's lawsuit, which was filed November 27, alleges that the FDA "repeatedly ignored [CRT's] requests" for information on animal-to-human transplant clinical trials.

"We want to court to rule that the FDA violated the Freedom of Information Act (FOIA) by withholding [xenotransplantation clinical data], CRT spokeswoman Alix Fano said, according to Reuters Health.

Fano claimed that based on a survey of medical journals by CRT more than 12 patients have died and numerous others have suffered serious side effects in the past 10 years after receiving tissue or organs from pigs and baboons.

An FDA spokesperson shrugged off the group's allegations, saying that the agency routinely responds to various groups regarding "why we do what we do and that the FDA's policy on xenotransplantation has been "well dealt with" through current public guidelines.
COPYRIGHT 2000 Transplant Communications, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2000 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Transplant News
Article Type:Brief Article
Date:Dec 29, 2000
Words:178
Previous Article:Canada seeking public input on xenotransplantation before allowing clinical trials.
Next Article:Majority of people would accept a xenotransplant, poll finds.


Related Articles
FDA publishes "guidance document" for transplant industry to follow in xenotransplantation research.
Canada seeking public input on xenotransplantation before allowing clinical trials.
FDA proposed rule requires public access to information on gene therapy, xenotransplantation clinical trials.
Public advisory panel recommends ban on xenotransplant trials on humans until "critical issues" solved.
Countries scrambling to draft guidelines for xenotransplantation human clinical trials.
What's the difference? Comparing the advocacy preferences of state and federal appellate judges.
Public Citizen seeks 'black-box' warning for popular antibiotics.

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters |